United States · FDA National Drug Code directory
FENOFIBRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-5522_949bb30f-2572-4556-ab55-b31a54dd806b
- Product NDC
- 60219-5522
- Form
- TABLET
- Composition / generic term
- FENOFIBRATE
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220622
- Source listing expiry
- 20271231
Source-listed ingredients
- FENOFIBRATE — 160 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (60219-5522-5) · 60219-5522-5
- 90 TABLET in 1 BOTTLE (60219-5522-9) · 60219-5522-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →